| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |